PARP1 and ovarian neoplasm: In mice bearing advanced subcutaneous and IP ovarian tumours (SKOV3 and OVCAR8), PTP liposomes incorporating AZ739 increased PARP inhibition, leading to slower tumour growth and an overall 3- and 1.7-fold decrease in tumour volumes [145].